Pluristem Therapeutics (PSTI) CEO Zami Aberman To Speak On Panel At 9th Annual Stem Cell Summit On February 18, 2014
2/13/2014 9:36:31 AM
HAIFA, Israel, Feb. 13, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced that its CEO and Chairman, Zami Aberman, will be a speaker on a panel titled, "Disrupting the Pharma Model with Allogeneic Stem Cell Therapies - Part I" at the 9th Annual Stem Cell Summit. The summit will take place in New York on Tuesday, February 18th, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by